title: [Prophylaxis and correction of inflammatory complications in peritonitis, depending on severity of enteral insufficiency].
abstract: There were examined 54 patients, in whom peritonitis of various etiology was diagnosed. Clinical, biochemical, immunological and other investigations were conducted for estimation of the enteral insufficiency syndrome severity. Basing on the analysis of the data obtained and criterions of the patient common state there was determined the occurrence risk for inflammatory complications (IC). Complex of prophylactic and therapeutic measures for reduction of the IC rate was proposed.
authors.forename: F N
authors.initials: FN
authors.lastname: Il'chenko
authors.forename: N V
authors.initials: NV
authors.lastname: Liashenko
authors.forename: I V
authors.initials: IV
authors.lastname: Kaminskiĭ
authors.forename: M M
authors.initials: MM
authors.lastname: Serbul
authors.forename: V A
authors.initials: VA
authors.lastname: Goncharuk
mesh_terms: D000328:Adult; D004731:Endotoxins / Q000097:blood; D016061:Enterosorption; D005260:Female; D006801:Humans; D007249:Inflammation / Q000209:etiology / Q000276:immunology / Q000517:prevention & control / Q000601:surgery; D015850:Interleukin-6 / Q000097:blood; D007441:Intubation, Gastrointestinal; D008297:Male; D008536:Meglumine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D010538:Peritonitis / Q000150:complications / Q000276:immunology / Q000601:surgery / Q000628:therapy*; D012720:Severity of Illness Index; D017640:Silicates / Q000627:therapeutic use; D013386:Succinates / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000097:blood
chemical_list: D004731:Endotoxins; D015850:Interleukin-6; C549374:Reamberin; D017640:Silicates; D013386:Succinates; D014409:Tumor Necrosis Factor-alpha; D008536:Meglumine; C033214:Smectite